Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,230.71
(
-0.16%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
78,133.54
(
0.66%
)
News Focus
News Focus
Post# of 517596
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Steady_T

Send PM Follow Ignore
Followers 170
Posts 23061
Boards Moderated 1
Alias Born 12/09/2004

Steady_T

Member Level

Re: georgejjl post# 379550

Monday, 10/24/2022 1:47:09 AM

Monday, October 24, 2022 1:47:09 AM

Post# of 517596

Therefore it does not appear that concomitent use of donepezil (Aricept) is allowed for this trial.



It is not excluded so that means that a trial subject can be taking it.

What is specified is that any trial subject has to taking and stable on any psychoactive drug for 3 months prior to starting the trial.

As I pointed out in a previous post, most of the improvement that comes from taking Aricept occurs in the first 3 to 6 weeks. So any benefit from taking Aricept would be included in the baseline.

If investing was easy, everyone would be rich by now.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News